Share Your Research, Maximize Your Social Impacts
Main Menu
Searching By
PARTNERS
2020 - Clinical Study Risk Management including Compliance During The COVID-19
Date2020-07-15
Deadline2020-07-05
VenueOnline event, USA - United States 
KeywordsRisk management; The latest focus; GCP inspection
Topics/Call fo Papers
Understand the new requirements for risk management in clinical trials including the latest EMA and FDA guidance on risk management during Covid-19
Define the regulations and guidelines which cover risk management and Covid-19 applied to clinical study-level risk management
Consider the elements of QM system are and what a regulatory inspector would expect to be in place for clinical trials
Have explained key risk-based process/tools and techniques including RBM and FDA and EMA recommendations during Covid-10
Review a risk-based approach to protocol design
Hear best practice of these new management risk requirements during Covid-19
Define the regulations and guidelines which cover risk management and Covid-19 applied to clinical study-level risk management
Consider the elements of QM system are and what a regulatory inspector would expect to be in place for clinical trials
Have explained key risk-based process/tools and techniques including RBM and FDA and EMA recommendations during Covid-10
Review a risk-based approach to protocol design
Hear best practice of these new management risk requirements during Covid-19
Other CFPs
- How Can Leaders and HR Professionals Manage the COVID-19 Pandemic in the Workplace -- Impact on Employees’ Employment, Finances, and Emotional Wellbeing
- The Family & Medical Leave Act, California Family Rights Act & Pregnancy Disability Leave: Managing Employee Leave & Possible Abuse
- Employee Expense Reimbursement Fraud: Detection, Prevention and Deterrence
- Metrics for a Suitable and Effective Quality Management System
- The Veterinary Drug Approval Process and FDA Regulatory Oversight
Last modified: 2020-06-24 22:55:23